O008/#785 A Multicenter, Open-Label, Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib in Combination with Pembrolizumab Vs Treatment of Physician’s Choice in Patients with Advanced Endometrial Cancer: Study 309/Keynote-775

AuthID
 P-00V-TAW
20
Author(s)
Makker, V
·
Colombo, N
·
Casado Herráez, A
·
Santin, A
·
Colomba, E
·
Fujiwara, K
·
Pignata, S
·
Baron-Hay, S
·
Ray-Coquard, I
·
Shapira, R
·
Ushijima, K
·
Sakata, J
·
Yonemori, K
·
Kim, Y
·
Guerra, E
·
Sanli, U
·
Mccormack, M
·
Huang, J
·
Smith, A
Document Type
Proceedings Paper
Year published
2021
Published
in Oral Abstracts
Indexing
Crossref®5
Google Scholar®
Publication Identifiers
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service